
    
      Primary outcome: Changes in androgen concentrations and menstrual pattern

      Secondary outcome: changes in sympathetic nerve activity, uterus peristalsis, ovarian
      morphology, adipose tissue related variables, insulin sensitivity, coagulation factors and
      health related quality of life and symptoms of anxiety and depression.
    
  